ArticleDisease markers2018

CRISPR/Cas9 Genome Editing of Epidermal Growth Factor Receptor Sufficiently Abolished Oncogenicity in Anaplastic Thyroid Cancer.

Li-Chi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.